The new fact already makes great noise in the Western medical world. Americans are crazy with rage. Cuban researchers say CIMAVAX EGF, a Cuban vaccine against lung cancer, has proved its effectiveness.
Millions of patients in the world will be able to be saved. According to the CCN correspondent, Cuban research gives priority to fighting cancer. Lung cancer is considered one of the most serious, frequent and fatal cancers in the world. The World Health Organization has reported that the disease kills 5 million people annually and the trend is on the rise.
It is estimated that in 2030 8 million people will die per year of this disease. In Cuba, 20,000 people die each year from lung cancer. It is the leading cause of death in 12 of the 15 Cuban provinces. Researchers at the Havana Molecular Immunology Center have developed the Cimavax EGF therapeutic vaccine, the result of 25 years of research into tobacco-related diseases.
Dr. Gisela Gonzalez, who led the team of researchers who created the vaccine, believes that with this drug lung cancer could become a chronic, controllable disease because the vaccine promotes the generation of antibodies against the proteins that trigger proliferation Without control of carcinogenic cells. The vaccine is applied in patients with advanced lung cancer (stage 3 and 4) who have no positive response to other treatments such as chemotherapy and radiotherapy. It significantly improves the quality of life of terminal patients.